Study of Oglemilast for the Treatment of Asthma

Completed · Phase 2 · Has a placebo group

Conditions studied: Asthma

In brief

The purpose of this study is to determine whether oglemilast is safe and effective in the treatment of allergen-induced asthma.

Key facts

Study ID

NCT00322686

Run by

Forest Laboratories

People needed

6

Starts

2006-05-01

Last updated by the study team

2012-03-20

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Mild atopic asthma
• Hyperreactivity to methacholine
• Exhibit positive response to standard allergen skin prick test

You may not qualify if…

• Pulmonary disease other than asthma
• Asthma exacerbation within 4 weeks
• History of substance abuse
• Active cardiac disease

Where it is running

• Forest Investigative Site — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.